Redcare Pharmacy gains 0.48 percent pre-market to EUR 73.05

Published on 10/09/2026 at 08:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lang & Schwarz priced Redcare Pharmacy at EUR 73.05 pre-market on October 9, 2026. The company’s next scheduled event is its Q3 interim statement on October 29.

Key points in brief

Redcare Pharmacy gains 0.48 percent pre-market to EUR 73.05.
The bid is EUR 72.75 and the ask is EUR 73.35.
Q3 results and a conference call are scheduled for October 29, 2026.

Flatlay mit Aktienzertifikat, ISIN-Karte, Pillenblistern und Stethoskop von oben — Redcare Pharmacy (Shop Apoth), ISIN NL0012044747, zeigt Flatlay mit Aktienzertifikat, ISIN-Karte und markenfreien Apotheken-Utensilien, Illustration mit AI erstellt.

Redcare Pharmacy stock was at EUR 73.05 pre-market at 8:28 a.m. CEST on October 9, 2026, at Lang & Schwarz, up plus 0.48 percent versus the prior close of EUR 72.70 on October 8, 2026.

Pre-market trading

The bid was EUR 72.75 and the ask was EUR 73.35. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Redcare Pharmacy stock.

What matters today

The next scheduled company date is October 29, 2026, when Redcare Pharmacy will publish its third-quarter interim statement and hold its quarterly conference call, according to its Investor Relations release. A round-number level of EUR 75.00 is 2.67 percent above the pre-market price. Structured quote data recorded a P/E of minus 34.93 as of October 8, 2026.

Market context: Market report SDAX.

More news and analysis on Redcare Pharmacy stock